Healthcare and Pharmaceuticals
GLOBAL BONE GROWTH STIMULATOR MARKET was valued at USD 1.15 Billion in the year 2017. Global Bone Growth Stimulator market is further estimated to grow at a CAGR of 4.13% from 2018 to reach USD 1.46 Billion by the year 2023. North America region holds the highest market share in 2017 and Asia-Pacific market is considered as the fastest growing market in the forecasted period due to growing old age population. At a country level, the U.S in North America whereas India and China in Asia-Pacific is projected to grow strongly in the coming years.
Medtronic. Plc (Ireland), Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Bioventus LLC, DePuy Synthes (U.S.) and Harvest Technologies Corporation (U.S.) are some of the key players in the Global Bone Growth Stimulator market. Better global reach at an operational level is the main reason the key players are holding substantial market share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.
Growing old age population
Adoption of minimal surgical treatment
High treatment costs
Rising pharma sector in emerging market
Government Regulations and norms.
The segmentation are done on the basis of product type, by application, by end users and by region. On the basis of product types, the global Bone Growth Stimulator market is sub segmented as Bone Morphogenetic Proteins, Bone Growth Stimulation Devices and Platelet-Rich Plasma of which the Bone Growth Stimulation Devices segment is expected to hold the highest market share during the forecast period.
The segmentation done on the basis of application includes Delayed Union & Nonunion Bone Fractures, Oral and Maxillofacial Surgeries, Spinal Fusion Surgeries and Other Applications of which the Spinal Fusion Surgeries segment is expected to hold the highest market share among other applications. On the basis of end users the market is segmented as hospitals & clinics, home Care and others of which hospitals & clinics is expected to grow at the highest CAGR during the forecasted period.
Key Benefits for Stakeholders
Bone Growth Stimulator Manufacturers, Distributors and Retailers
Research and Consulting Organization
Technology Standards Organizations, Forums, Alliances and Associations
End use industries
Regulatory bodies, policy actors and consumers.
Bone Morphogenetic Proteins
Bone Growth Stimulation Devices
External Bone Growth Stimulators
Implanted Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Delayed Union & Nonunion Bone Fractures
Oral and Maxillofacial Surgeries
Spinal Fusion Surgeries
Hospitals & Clinics
Key Market Players
Regen Lab SA
Altis Biologics (Pty) Ltd
Johnson & Johnson (J&J)
DJO Global, Inc.
Terumo BCT, Inc.
Harvest Technologies (A Terumo BCT Company)
Orthofix International N.V.
(A brief overview of 13 companies is also provided)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
22.214.171.124. Key Data from Secondary Research
2.1.2. Primary Research
126.96.36.199. Key Data from Primary Research
188.8.131.52. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Bone Growth Stimulator Market, By Product
6.1 Bone Morphogenetic Proteins
6.2 Bone Growth Stimulation Devices
6.2.1 External Bone Growth Stimulators
6.2.2 Implanted Bone Growth Stimulators
6.2.3 Ultrasonic Bone Growth Stimulators
6.3 Platelet-Rich Plasma
7. Bone Growth Stimulator Market, By Application
7.1 Delayed Union & Nonunion Bone Fractures
7.2 Oral and Maxillofacial Surgeries
7.3 Spinal Fusion Surgeries
7.4 Other Applications
8. Bone Growth Stimulator Market, End Users
8.1 Hospitals & Clinics
8.2 Home Care
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Medtronic, plc
10.2 Stryker Corporation
10.3 Arthrex, Inc.
10.4 Regen Lab SA
10.5 Altis Biologics (Pty) Ltd
10.6 Johnson & Johnson (J&J)
10.7 DePuy Synthes
10.8 DJO Global, Inc.
10.9 Terumo BCT, Inc.
10.10 Harvest Technologies (A Terumo BCT Company)
10.12 Orthofix International N.V.
(A brief overview of 13 companies is also provided.)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
No Content Available.